By analyzing a tissue array containing 153 human lung cancer samples and 31 normal human lung tissues, we demonstrated that the level of activated, phosphorylated p38 is significantly downregulated in lung tumors as compared to normal tissues, thus supporting the notion that activated p38 suppresses human lung cancer development. This evidence concerns the gene MAPK14 and lung carcinoma.